Top Markets
Coin of the day
Advanced Proteome Therapeutics Corporation Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Clasificación en acciones #40426
Advanced Proteome Therapeutics Corporation, operating through its subsidiary... Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Precio por acción
$0.0002
Última sincronización: 2025-05-15
Capitalización bursátil
$149.63K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Advanced Proteome Therapeutics Corporation (APTCF)

Categoría

Ratio P/S de Advanced Proteome Therapeutics Corporation (APTCF)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Advanced Proteome Therapeutics Corporation, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Advanced Proteome Therapeutics Corporation desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE